Myriad Genetics Partners with Institut für Hämopathologie

Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad’s commitment to growing...

Related Keywords

Germany ,Hamburg ,Denmark ,Copenhagen ,Køavn ,France ,Mychoice Cdx ,Megan Manzari ,Bracanalysis Cdx ,Foster Harris ,Nicole Lambert ,Genetics Inc ,Exchange Commission ,Centre Georges Francois Leclerc ,Fast Company ,Institute Of Pathology ,World Most Innovative Companies ,Nasdaq ,Plus Testing ,Homologous Recombination Deficiency ,Genomic Instability Score ,Chief Operating Officer ,Most Innovative Companies ,Myriad Myrisk ,Myrisk Hereditary Cancer ,Health Illuminated ,Myriad Genetics ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Nasdaq Mygn ,Nc ,Enetics ,Health ,Ncology ,Science ,